156 related articles for article (PubMed ID: 10459134)
1. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma.
Fimiani M; Rubegni P; De Aloe G; Andreassi L
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):502-3. PubMed ID: 10459134
[No Abstract] [Full Text] [Related]
2. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
Stadler R; Otte HG
Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
Dippel E; Schrag H; Goerdt S; Orfanos CE
Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
[No Abstract] [Full Text] [Related]
4. [Combination therapy with interferon alfa 2a and PUVA in cutaneous T-cell lymphoma].
Otte HG; Herges A; Stadler R
Hautarzt; 1992 Nov; 43(11):695-9. PubMed ID: 1468931
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
[TBL] [Abstract][Full Text] [Related]
6. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a.
Springer EA; Kuzel TM; Variakojis D; Kaul K; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1993 Jul; 29(1):42-6. PubMed ID: 7686188
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH
J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954
[TBL] [Abstract][Full Text] [Related]
9. De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma.
Wolfe JT; Singh A; Lessin SR; Jaworsky C; Rook AH
J Am Acad Dermatol; 1995 May; 32(5 Pt 2):887-93. PubMed ID: 7722051
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet radiation for treatment of cutaneous T-cell lymphoma.
Herrmann JJ; Roenigk HH; Hönigsmann H
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1077-88. PubMed ID: 8522485
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids.
Knobler RM; Trautinger F; Radaszkiewicz T; Kokoschka EM; Micksche M
J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):247-52. PubMed ID: 2007670
[TBL] [Abstract][Full Text] [Related]
12. Interferons for cutaneous T-cell lymphoma monotherapy or combination with PUVA.
Roenigk HH; Kuzel T; Rosen S
Australas J Dermatol; 1993; 34(1):13-5. PubMed ID: 8240181
[No Abstract] [Full Text] [Related]
13. Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
Ann N Y Acad Sci; 2001 Sep; 941():210-3. PubMed ID: 11594576
[No Abstract] [Full Text] [Related]
14. Current management strategies for cutaneous T-cell lymphoma.
Knobler E
Clin Dermatol; 2004; 22(3):197-208. PubMed ID: 15262305
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy followed by local injections of interferon-alpha is effective for treating cutaneous-type adult T-cell leukaemia/lymphoma.
Takemori N; Hirai K; Onodera R; Saito N; Watanabe S; Namiki M
Br J Dermatol; 1993 Dec; 129(6):746-7. PubMed ID: 8286266
[No Abstract] [Full Text] [Related]
16. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
17. [Interferon-alpha in cutaneous T-cell lymphoma].
Knobler R
Wien Med Wochenschr; 1993; 143(16-17):435-7. PubMed ID: 8273368
[TBL] [Abstract][Full Text] [Related]
18. International symposium on cutaneous T cell lymphoma. Chicago, Illinois, Oct. 19-21, 1989.
Springer EA; Kuzel TM; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1991 Jan; 24(1):136-8. PubMed ID: 1999510
[No Abstract] [Full Text] [Related]
19. ["Granulomatous slack skin"--cutaneous elastolytic lymphoma].
von den Driesch P; Mielke V; Simon M; Staib G; Tacke J; Sterry W
Hautarzt; 1994 Dec; 45(12):861-5. PubMed ID: 7843967
[TBL] [Abstract][Full Text] [Related]
20. Partial regrowth of scalp hair in a patient treated with extracorporeal photochemotherapy and interferon alpha 2a.
Wollina U
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):261-2. PubMed ID: 9883441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
